135 related articles for article (PubMed ID: 3378654)
1. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
2. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
3. HLA and skin cancer.
Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
[TBL] [Abstract][Full Text] [Related]
4. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
5. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
Hua LA; Kagen CN; Carpenter RJ; Goltz RW
Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
[TBL] [Abstract][Full Text] [Related]
6. HLA molecules in basal cell carcinoma of the skin.
Cabrera T; Garrido V; Concha A; Martín J; Esquivias J; Oliva MR; Ruiz-Cabello F; Serrano S; Garrido F
Immunobiology; 1992 Sep; 185(5):440-52. PubMed ID: 1452215
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigens and multiple basal cell carcinomas.
Rompel R; Petres J; Kaupert K; Müller-Eckhardt G
Recent Results Cancer Res; 1995; 139():297-302. PubMed ID: 7597298
[TBL] [Abstract][Full Text] [Related]
8. Multiple basal cell carcinomas: no association with HLA-DRB, HLA-DQA1 or HLA-DQB1 in Swedish patients.
Emtestam L; Wallberg P; Aldener A; Olerup O
Br J Dermatol; 1996 May; 134(5):886-91. PubMed ID: 8736330
[TBL] [Abstract][Full Text] [Related]
9. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
10. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma.
Kohchiyama A; Oka D; Ueki H
J Am Acad Dermatol; 1987 Apr; 16(4):833-8. PubMed ID: 2952686
[TBL] [Abstract][Full Text] [Related]
11. The distribution of HLA-A, B, C, DR antigens in Chinese patients with hepatocellular carcinoma in Taiwan.
Lin DY; Liaw YE; Huang CC
Tissue Antigens; 1987 Feb; 29(2):110-4. PubMed ID: 3037726
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
13. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen associations in basal cell carcinoma.
Myskowski PL; Pollack MS; Schorr E; Dupont B; Safai B
J Am Acad Dermatol; 1985 Jun; 12(6):997-1000. PubMed ID: 3874217
[TBL] [Abstract][Full Text] [Related]
15. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
16. Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers.
Czarnecki D; Tait B; Nicholson I; Lewis A
Dermatology; 1994; 188(2):88-90. PubMed ID: 8136554
[TBL] [Abstract][Full Text] [Related]
17. Multiple basal cell carcinomas and HLA frequencies in southern Australia.
Czarnecki D; Lewis A; Nicholson I; Tait B
J Am Acad Dermatol; 1991 Apr; 24(4):559-61. PubMed ID: 2033130
[TBL] [Abstract][Full Text] [Related]
18. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
19. Haplotype frequencies in south-east Scotland.
Jazwinska EC; Kilpatrick DC
Tissue Antigens; 1987 Feb; 29(2):115-9. PubMed ID: 3474807
[TBL] [Abstract][Full Text] [Related]
20. No HLA association with the early development of a single basal cell carcinoma.
Czarnecki D; Nicholson I; Tait B; Meehan C
Dermatology; 1995; 190(1):88. PubMed ID: 7894109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
